These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19141588)

  • 1. Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes.
    Rabøl R; Højberg PM; Almdal T; Boushel R; Haugaard SB; Madsbad S; Dela F
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1372-8. PubMed ID: 19141588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetes.
    Rabøl R; Boushel R; Almdal T; Hansen CN; Ploug T; Haugaard SB; Prats C; Madsbad S; Dela F
    Diabetes Obes Metab; 2010 Sep; 12(9):806-14. PubMed ID: 20649633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional anatomic differences in skeletal muscle mitochondrial respiration in type 2 diabetes and obesity.
    Rabøl R; Larsen S; Højberg PM; Almdal T; Boushel R; Haugaard SB; Andersen JL; Madsbad S; Dela F
    J Clin Endocrinol Metab; 2010 Feb; 95(2):857-63. PubMed ID: 20061415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved glycaemic control decreases inner mitochondrial membrane leak in type 2 diabetes.
    Rabøl R; Højberg PM; Almdal T; Boushel R; Haugaard SB; Madsbad S; Dela F
    Diabetes Obes Metab; 2009 Apr; 11(4):355-60. PubMed ID: 19267714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic insulin aspart 30: better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes.
    Velojic-Golubovic M; Mikic D; Pesic M; Dimic D; Radenkovic S; Antic S
    J Endocrinol Invest; 2009 Jan; 32(1):23-7. PubMed ID: 19337010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin-treated patients with type 2 diabetes have normal mitochondrial complex I respiration.
    Larsen S; Rabøl R; Hansen CN; Madsbad S; Helge JW; Dela F
    Diabetologia; 2012 Feb; 55(2):443-9. PubMed ID: 22009334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes.
    Christiansen JS; Vaz JA; Metelko Z; Bogoev M; Dedov I
    Diabetes Obes Metab; 2003 Nov; 5(6):446-54. PubMed ID: 14617231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic insulin aspart 30 improved glycemic control in Chinese patients with type 2 diabetes poorly controlled on oral glucose-lowering drugs: a subgroup analysis of the A₁chieve study.
    Chen L; Xing X; Lei M; Liu J; Shi Y; Li P; Qin G; Li C; Li Y; Wang Q; Gao T; Hu L; Wang Y; Yang W
    Chin Med J (Engl); 2014; 127(2):208-12. PubMed ID: 24438605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fasting capillary glucose variability between insulin glargine and NPH.
    Mu P; Lu H; Zhang G; Chen Y; Fu J; Wang M; Shu J; Zeng L
    Diabetes Res Clin Pract; 2011 Jan; 91(1):e4-7. PubMed ID: 20970870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial.
    Kaneko S; Chow F; Choi DS; Taneda S; Hirao K; Park Y; Andersen TH; Gall MA; Christiansen JS;
    Diabetes Res Clin Pract; 2015 Jan; 107(1):139-47. PubMed ID: 25498130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waist circumference reduction after insulin detemir therapy in type 2 diabetes patients previously treated with NPH.
    Mandosi E; Fallarino M; Rossetti M; Gatti A; Morano S
    Diabetes Res Clin Pract; 2009 May; 84(2):e18-20. PubMed ID: 19297054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
    Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
    Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin detemir improves glycemic control and reduces hypoglycemia in children with type 1 diabetes: findings from the Turkish cohort of the PREDICTIVE observational study.
    Kurtoglu S; Atabek ME; Dizdarer C; Pirgon O; Isguven P; Emek S;
    Pediatr Diabetes; 2009 Sep; 10(6):401-7. PubMed ID: 19220776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
    Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
    Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis.
    Davidson JA; Liebl A; Christiansen JS; Fulcher G; Ligthelm RJ; Brown P; Gylvin T; Kawamori R
    Clin Ther; 2009 Aug; 31(8):1641-51. PubMed ID: 19808125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of the pathogenetic defects in type 2 diabetes: the randomized multicenter South Danish Diabetes Study.
    Gram J; Henriksen JE; Grodum E; Juhl H; Hansen TB; Christiansen C; Yderstræde K; Gjessing H; Hansen HM; Vestergaard V; Hangaard J; Beck-Nielsen H
    Diabetes Care; 2011 Jan; 34(1):27-33. PubMed ID: 20929990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.
    Rosenstock J; Schwartz SL; Clark CM; Park GD; Donley DW; Edwards MB
    Diabetes Care; 2001 Apr; 24(4):631-6. PubMed ID: 11315821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy.
    Raz I; Mouritzen U; Vaz J; Hershkovitz T; Wainstein J; Harman-Boehm I
    Clin Ther; 2003 Dec; 25(12):3109-23. PubMed ID: 14749149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes.
    Franek E; Haluzík M; Canecki Varžić S; Sargin M; Macura S; Zacho J; Christiansen JS
    Diabet Med; 2016 Apr; 33(4):497-505. PubMed ID: 26435365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.
    Hermansen K; Fontaine P; Kukolja KK; Peterkova V; Leth G; Gall MA
    Diabetologia; 2004 Apr; 47(4):622-9. PubMed ID: 15298338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.